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Abstract
Background: Meningiomas are associated with the highest postoperative rate of venous thromboembolic events (VTE)
among all intracranial tumors. The aim of this study is to compare two entirely different VTE prophylaxis regimens in 724
consecutive patients undergoing meningioma surgery.
Methods: Two cohorts at a single institution treated with different regimens to prevent VTE were reviewed retrospectively.
Cohort A (n = 482; 314 females, mean age 57 years, range: 11–87 years) received our institutional regimen during the years
1999–2006, consisting of low-molecular-weight heparin (LMWH) and compression stockings. For cohort B (n = 242; 163
females, mean age 56.8 years, range: 16–90 years), during the years 2008–2010, the management included intraoperative
10u–20u leg elevation with intermittent pneumatic compression (IPC), heparin and LMWH administration. We compared the
incidence of the endpoints pulmonary embolism (PE), deep venous thrombosis (DVT), hemorrhage and death, taking into
account several known associated risk factors.
Results: For all endpoints, we observed a more favorable outcome with the new regimen. The difference in incidence of PEs
(cohort A: 38/482, 8%; cohort B: 6/242, 2.5%) reached statistical significance (p = 0.002). In general, patients with skull base
meningiomas had a higher risk for PE (OR 2.77). Regarding VTE prophylaxis, an adjusted subgroup analysis suggests that the
new regimen is particularly beneficial for patients with skull base meningiomas.
Conclusions: We recommend perioperative prophylaxis using a management composed of intraoperative leg-elevation,
IPC, early heparin administration and LMWH to reduce the risk for PE.
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Introduction
Meningiomas represent the second most frequent primary
intracranial tumor in adults [1], with a prevalence of approx-
imately 70.7/100 000 and an incidence of 6.0/100 000 per year in
the United States (www.cbtrus.org).[2].
Venous thromboembolism (VTE), including deep vein throm-
bosis (DVT) and pulmonary embolism (PE), is the most common
overall complication in meningioma surgery and is fatal in up to
34% of subjects.[3,4] The VTE risk is three times higher in
meningioma patients than in patients with other brain tumors,
such as gliomas or brain metastases.[5,6,7].
The incidence of VTE in meningioma was shown to be as
high as 72% using sensitive methods such as 125I-fibrinogen-
uptake tests.[8] Several factors explaining this high incidence of
VTE have been discussed in the past. The observed hyperco-
agulable state may be tumor induced.[6,7,9] Blood coagulation
can be activated through the meningeal surface [1] or through
damage to the vascular endothelium as a direct consequence of
surgery, trauma or prior VTE.[10,11] Brain surgery releases
brain thromboplastin, altering the coagulative state.[12] Immo-
bilization, due to intraoperative muscle relaxation, surgery of
long duration or preoperative tumor-related muscle weakness of
the lower extremities, results in a venous stasis that can be
aggravated by postoperative bed rest.[7] Furthermore, the
perioperative use of high-dose steroids as a treatment for
tumor-induced vasogenic brain edema was reported as another
contributing factor [12].
Preventive measures including compression stockings, early
mobilization and the administration of heparin are thought to
lower morbidity, but the usefulness of these measures needs
quantification.
It has been shown that the prophylaxis of VTE is most effective
when mechanical and pharmacological prophylaxis are com-
bined.[7,13,14].
However, there is still controversy over the use of unfractionated
heparin (UFH) and LMWH after meningioma resec-
tion.[1,6,15,16] It is also known that only 76.2% of surgeons use
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mechanical DVT prophylaxis during brain tumor surgery, and
LMWH was not regularly used in 72.7%.[17].
The aim of this study is to compare two entirely different
perioperative management strategies in a single institution
regarding safety and the prevention of VTE.
Methods
Study Design and Patient Population
We retrospectively analyzed all patients undergoing surgical
treatment at our institution for an intracranial meningioma in the
time period from 1999 to 2010. Because, in 2007,a new
department chairman introduced a change in our institutional
policy regarding the perioperative management to prevent VTE,
we formed two cohorts - cohort A receiving the former regimen
(before 2007) and cohort B receiving the novel regimen (after
2007), as depicted in Table 1.
We considered and documented four clinical endpoints:
hemorrhage, death, PE and DVT. The combination of PE and
DVT as well as the presence of overall complication were
investigated as two additional endpoints. Clinical data were
obtained from the patient records at discharge and at three
months after discharge.
The data were collected retrospectively, and the patients’
written consent was not obtained. The retrospective data
collection without consent was approved by the local ethics
committee (KEK 2011-0138, KantonaleEthikkommission Zu¨rich).
Cohort A: Perioperative management 1999–2006. Cohort
A included all patients undergoing craniotomy for meningioma
resection during the years 1999–2006. The management consisted
of the following:
1. Perioperative physical prophylaxis with compression stockings
until full mobilization of the patient.
2. Administration of LMWH prophylaxis, which was given on the
first postoperative day if the postoperative CT-scan (also
performed on the first postoperative day) showed no significant
bleeding. LMWH (FragminH) 5000 IE/24 h was administered
subcutaneously until hospital discharge. Subjects lighter than
65 kg bodyweight were administered 2500 IE Fragmin, while
subjects heavier than 80 kg bodyweight received 7500 IE.
Cohort B: Perioperative management 2008–2010. Cohort
B was treated during the years 2008–2010. The management
comprised three parts:
1. Intermittent pneumatic compression (IPC, Tyco Healthcare,
KENDALL, SCD EXPRESS TM) was installed preoperatively
and throughout surgery in addition to conventional compres-
sion stockings. IPC was maintained postoperatively until full
mobilization.
2. The legs were elevated intraoperatively by 10u–20u to facilitate
venous backflow.
3. A cranial CT control was performed within two hours after
surgery to exclude hemorrhage. In the absence of bleeding
complications, UFH was initiated on the day of surgery. UFH
was applied continuously intravenously at 4.5 IE/kg body-
weight - the dosage was monitored under ICU surveillance. On
the first postoperative day, UFH was stopped at 4 pm and
replaced by 5000 IE LMWH (FragminH),which was adminis-
tered subcutaneously at 8 pm and continued once a day until
discharge. Subjects lighter than 65 kg bodyweight were
administered 2500 IE LMWH/24 h, while subjects heavier
than 80 kg bodyweight were given 7500 IE LMWH/24 h.
Data Collection
The following general parameters were collected by reviewing
the patient medical charts:
Age, sex, body mass index (BMI), histological grade and
location of the meningioma, pre-surgical endovascular tumor
embolization, duration of surgery(time interval from skin opening
to skin closure), and pre-and postoperative neurological exam
focusing on the presence and severity of weakness or paresis
according to the Medical Research Council (MRC) Scale for
muscle strength.
Hemorrhage, death, DVT and PE were checked by carefully
reviewing the medical charts, including the routine 3-month
postoperative follow-up notes. Any of these events counted for
‘‘overall complication’’. Postoperative bleeding was evaluated by
reviewing the postoperative cranial CT imaging. Hemorrhage was
classified as major when it was described with the terms
‘‘rebleeding’’, ‘‘fluid-level’’ or ‘‘large’’ on the radiologist’s report.
The assessment of DVT and PE was not based on routine
surveillance - testing for both complications was initiated in cases
of clinical suspicion (DVT: swelling, pain or tenderness, warmth,
redness or discoloration and distention of surface veins of an
extremity; PE: new onset dyspnea, tachypnea, tachycardia, chest
pain, hemodynamic instability). The diagnosis of DVT was
verified by duplex sonography of the leg vessels in every case,
and PE was always confirmed by multi-slice, contrast-enhanced
chest CT.
We excluded ten patients lacking complete follow up: six
patients who went abroad after surgery and four patients with
incomplete patient records. Thus, 734 consecutive patients who
were operated on between 1999 and 2010 and 724 (98.6%) were
followed and included in this study.
Table 1. PE prophylaxis managements of cohort A and cohort B.
Cohort A (1999–2006) Cohort B 2008–2010
intraoperatively: compressionstockings IPC
legsextended 10u–20u
post-operatively: – cranial CT
– Heparin (Liquemin)
1st postoperative day: cranial CT LMWH (Fragmin) untildischarge
LMWH (Fragmin) untildischarge
IPC = intermittent pneumatic compression, LMWH= low molecular weight heparin.
doi:10.1371/journal.pone.0079170.t001
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Statistical Methods
Statistical analyses were performed using the commercially
available software IBM SPSS Statistics 20 (SPSS Inc., Chicago, IL,
USA), and R version 2.15.2, (R Development Core Team, GNU
General Public License). Continuous variables are presented as
mean 6standard deviation (SD) and range. The patient charac-
teristics of the two cohorts were compared using the Mann-
Whitney U test or the chi-squared test, as appropriate.
For each outcome, we compared the proportion of cases in the
two cohorts using odds ratios (OR), risk differences (RD), and
corresponding numbers needed to treat (NNT). We also fitted
logistic regression models to adjust for potential confounders using
the AIC (Akaike information criterion) and the BIC (Bayesian
information criterion). Both are closely related statistical criteria
for model selection. Both criteria address the problem of
overfitting by penalizing the number of parameters in a model.
However, the BIC penalizes the number of parameters more
strongly than the AIC does.
Point estimates, 95% confidence intervals (CI) and p-values are
all likelihood-based. Two-tailed p values ,0.05 were considered
statistically significant.
First, we conducted an unadjusted comparison, without
considering any of the confounders (sex, location of the tumor,
WHO grade, embolization prior to surgery, paresis prior to
surgery, paresis post-surgery, paresis until 3 months after
discharge). Moreover, we performed a subgroup analysis for the
patients with skull base meningiomas.
As a second step, we also considered potential confounders. We
fitted full logistic regression models and applied backward
elimination of confounders based on the AIC criterion. As an
additional covariate, we considered the interaction of location
(skull base meningiomas vs. non-skull base meningiomas) with the
cohort indicator to assess differences in outcome parameters.
In addition, we explored whether nonlinear transformations of
the continuous covariates are necessary, using fractional polyno-
mials and splines. We did not find evidence that such transfor-
mations are necessary.
Results
Patient Population
Cohort A. Cohort A consisted of 482 patients undergoing
meningioma surgery between the years 1999 and 2006, whereas in
cohort B, 242 patients were operated on between 2008 and 2010.
In cohort A (n = 482; 314 females, 168 males; f:m=1.9), the
mean age was 57.0614.6 years (range:11–87 years). The mean
duration of surgery was 275.06142.7 minutes (range: 120–1020
minutes), and the mean duration of the hospital stay was 15.169.6
days (range: 5–93). The average BMI was 26.065.1 kg/m2 (range
16.0–47.8 kg/m2).
Skull base meningiomas were treated in 181 patients (38.5%).
Presurgical tumor embolization was performed in 202 subjects
(41.9%). Presurgical paresis was registered in 36 (7.5%) subjects.
Postsurgical paresis was observed in 52 (10.9%) and decreased to
29 patients (6.0%) 3 months after tumor resection.
Cohort B. In cohort B (n= 242; 163 females, 79 males;
f:m= 2.1), the mean age was 56.8614.5 years (range: 16–90
years). The mean duration of surgery was 311.46147.5 minutes
(range: 120–1015 minutes), and the mean duration of the hospital
stay was 13.768.8 days (range: 5–62). The average BMI was
26.064.8 kg/m2 (range 17.2–44.4 kg/m2).
Skull base meningiomas were treated in 81 patients (40.1%).
Presurgical tumor embolization was performed in 85 subjects
(35.1%). Presurgical paresis was registered in 20 (8.3%), and
postsurgical paresis was observed in 28 patients (11.6%) and
decreased to 19 patients (7.8%) 3 months after tumor resection.
The differences in important characteristics between the two
cohorts are summarized in Table 2 and 3. The only statistically
significant differences between the two cohorts were a shorter
hospital stay but a longer surgery duration in cohort B.
No significant differences between the cohorts were found
regarding age, sex, tumor location, WHO grade, BMI, emboli-
zation prior to surgery, paresis prior to surgery, paresis after
surgery and paresis until 3 months after discharge.
Endpoints (Unadjusted)
The outcome parameters (PE, DVT, hemorrhage, death, PE
and DVT, overall complication) are given for the time period from
admission until three months follow-up, unless specified otherwise
- detailed results can be found in Table 4.
For all endpoints, a trend toward a more favorable outcome in
cohort B was observed. However, a statistically significant
difference between the two cohorts was observed regarding the
incidence of PEs in cohort B with 2.5% (6/242) compared to
cohort A with 8% (38/482) (OR 0.3; CI 0.11–0.66; p = 0.0021), as
depicted in Figure 1.
Endpoints (Adjusted)
After adjustment for potential confounders (sex, location of the
tumor, WHO grade, embolization prior to surgery, paresis prior to
surgery, paresis post-surgery, paresis until 3 months after exit, age
in years, hospital stay in days, duration of surgery, body mass
index), the OR for PE decreased further to 0.24 (CI 0.05–0.78;
p = 0.02), as shown in Table 5. The OR for overall complications
decreased to 0.26 (CI, 0.28–1.06; p = 0.08).
Table 2. Four continuous covariates (age in years, hospital
stay in days, duration of surgery in minutes, body mass index)
were available.
Variable Levels n #NA x s Min Max
age cohort A 482 0 57.0 14.6 11 87
cohort B 242 0 56.8 14.5 16 90
p= 0.66 all 724 0 57.0 14.5 11 90
hospital stay
in days
cohort A 482 0 14.9 9.6 5 93
cohort B 237 5 13.6 8.8 5 62
p,0.001 all 719 5 14.5 9.4 5 93
surgery in
minutes
cohort A 482 0 248.8 145.2 120 1020
cohort B 239 3 289.4 152.4 120 1015
p,0.001 all 721 3 262.2 148.8 120 1020
BMI cohort A 335 147 26.0 5.1 16 45
cohort B 182 60 26.0 4.8 17 44
p= 0.79 all 517 207 26.0 5.0 16 48
The description of the continuous covariates (number of observations, number
of missing observations, mean, standard deviation and range) was split into the
surgery date cohorts. P-values of the Mann-Whitney test for a difference of the
means between the cohorts are printed in the first column.
doi:10.1371/journal.pone.0079170.t002
Reduced Thromboembolism in Meningioma Surgery
PLOS ONE | www.plosone.org 3 November 2013 | Volume 8 | Issue 11 | e79170
Associated Factors
Associated factors are shown in Table 3. For the endpoint ‘‘PE’’,
the variables skull base location, high BMI, and hospital stay were
significantly associated with a higher incidence.
Regarding the endpoint ‘‘DVT’’, the variable skull base location
of the tumor seemed to increase the morbidity in cohort A.
For the endpoint ‘‘hemorrhage’’, a longer hospital stay and
atypical meningioma (WHO grade II) were associated with an
elevated risk.
For the endpoint ‘‘death’’, no significant covariates were
observed.
Note that for the dependent variable ‘‘PE and DVT’’, the
algorithm did not converge, so no results are presented.
Table 3. The categorical variables are shown (sex, location of the tumor, WHO grade, embolization prior to surgery, paresis prior to
surgery, paresis post-surgery, paresis until 3 months after discharge).
Variable Levels ncohort A %cohort A ncohort B %cohort B nall %all
Sex female 314 65.2 163 67.4 477 65.9
male 168 34.9 79 32.6 247 34.1
p = 0.61 all 482 100 242 100 724 100
Location skull base 181 38.5 81 40.1 262 39
convexity 124 26.4 72 35.6 196 29.2
falx 96 20.4 21 10.4 117 17.4
intraventricular 2 0.4 1 0.5 3 0.5
parasagittal 0 0 27 13.4 27 4
posterior fossa 67 14.3 0 0 67 10
p,0.001 all 470 100 202 100 672 100
WHO-Grade one 379 79.5 179 76.5 558 78.5
two 80 16.8 47 20.1 127 17.9
three 18 3.8 8 3.4 26 3.7
p = 0.55 all 477 100 234 100 711 100
Preoperative tumor embolization no 280 58.1 157 64.9 437 60.4
yes 202 41.9 85 35.1 287 39.6
p = 0.093 all 482 100 242 100 724 100
Pre-op paresis no 443 92.5 222 91.7 665 92.2
yes 36 7.5 20 8.3 56 7.8
p = 0.84 all 479 100 242 100 721 100
Paresis at discharge no 427 89.1 214 88.4 641 88.9
yes 52 10.9 28 11.6 80 11.1
p = 0.87 all 479 100 242 100 721 100
Paresis three months post-op no 450 94 223 92.2 673 93.3
yes 29 6 19 7.8 48 6.7
p = 0.45 all 479 100 242 100 721 100
The P-values for chi-squared tests comparing the distributions between the two surgery date cohorts are depicted in the first column.
doi:10.1371/journal.pone.0079170.t003
Table 4. Unadjusted results for the whole data set (change from cohort A to cohort B): Risk differences (RD) and odds ratios (OR)
with 95% confidence intervals are given.
Endpoint cohort A cohort B RD CI OR CI p-value NNT
PE 8% 2.50% 25.5% (28.6%, 22.2%) 0.3 (0.11, 0.66) 0.002 19
DVT 4.80% 4.60% 20.2% (23.3%, 3.4%) 0.95 (0.44, 1.95) 0.9 457
Hemorrhage 6.70% 5% 21.7% (25.1%, 2.1%) 0.74 (0.36, 1.42) 0.37 60
Death 1.70% 0.80% 20.8% (22.5%, 1.1%) 0.49 (0.07, 1.99) 0.35 120
PE and DVT 2.70% 0.80% 21.9% (23.8%, 0.2%) 0.3 (0.05, 1.1) 0.072 53
overall complication 17% 11.70% 25.3% (210.4%, 0.2%) 0.65 (0.4, 1.02) 0.06 19
The p-value is a likelihood ratio p-value and thus identical for both comparison measures. The numbers needed to treat (NNT) were based on the estimated risk
difference.
doi:10.1371/journal.pone.0079170.t004
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Regarding the endpoint ‘‘overall complication’’, a longer
hospital stay and a skull base location were associated factors in
cohort B.
It was interesting that only for the endpoints ‘‘PE’’ and ‘‘overall
complication’’, other covariates (longer hospital stay, BMI and
skull base location of the tumor) were included in the best model in
terms of the Bayesian information criterion (BIC).
However, the estimates and p-values should be taken with
caution, as we have applied model selection.
BMI-dependent Incidence
The incidence of meningioma and the incidence of a high BMI
rose with age and a simultaneous increase in PE until the sixth
decade in the study population, as depicted in Figure 2.
The BMI of the study population was compared with the BMI
of the general population of Switzerland (www.bfs.admin.ch) older
than 15 years in 2007. Figure 3 shows that the group of the
overweight and obese is disproportionately overrepresented in our
study population and that normal weight patients (BMI 18.5–25)
benefited most from the new regimen (cohort B).
Subgroup Analyses
PE in skull base meningiomas. A total of 262 out of 724
patients (39%) were treated for a skull base meningioma (cohort A:
181/479, 38.5%; cohort B: 81/242, 40.1%). Patients with skull
base meningiomas showed a higher rate of PE in general, as
depicted in Figure 4. Cases with a skull base location had a higher
risk for PE (OR: 2.77 with 95% CI 1.15 to 7.07; p = 0.0096)
compared to subjects without skull base meningioma. In cohort A,
11.7% of the patients with skull base meningioma suffered a PE by
3 months postoperative follow-up, whereas in cohort B, only 3.8%
had a PE (unadjusted OR: 0.3; CI 0.07–0.9; p = 0.03; NNT 13).
PE in non-skull base meningiomas. In analogy to the skull
base meningioma group, the subgroup of patients with non-skull
base lesions also benefited from the novel anti-thrombotic regimen
(cohort B), but to a lesser degree. In the group of non-skull base
meningiomas, the rate of PE was 6% in cohort A and 1.7% in
cohort B, as shown in Figure 4. (Unadjusted OR: 0.26; CI 0.04–
0.94; p = 0.04; NNT 24).
PE in skull base meningiomas vs. non-skull base
meningiomas. When comparing the benefit of the new
regimen (cohort B) between the two subgroups (skull base
meningiomas vs. non-skull base meningiomas) and when addi-
tionally adjusting for the covariates mentioned above, there is a
statistically significant larger benefit for the subgroup of skull base
meningiomas from the novel anti-thrombotic regimen. The
adjusted odds ratio (adjusted OR 0.09 for change from cohort A
to cohort B) is significantly smaller in the skull base group than in
the non-skull base group (adjusted OR 0.71), p = 0.02 as shown in
Table 6.
Figure 1. Incidence of the primary endpoints of both applied
managements from admission until three months follow-up.
The endpoint ‘‘PE and DVT’’ showed concurrent PE and DVT. ‘‘Overall
complication’’ shows the appearance of any of the primary endpoints
PE, DVT, hemorrhage or death. Bars are in % of patients in each
management.
doi:10.1371/journal.pone.0079170.g001
Table 5. Adjusted odds ratio results for changes from cohort A to cohort B (all tumor locations).
Endpoint Odds Ratio 95% confidence interval p-value
PE in hospital 0.17 (0.02, 0.68) 0.01
PE duringfollow up 0.24 (0.05, 0.78) 0.02
DVT in hospital 0.74 (0.19, 2.34) 0.62
DVT during follow up 0.75 (0.22, 2.18) 0.61
hemorrhage in hospital 0.55 (0.19, 1.43) 0.23
hemorrhageduring follow up 0.56 (0.19, 0.45) 0.24
death in hospital – – –
death during follow up 1.37 (0.18, 7.66) 0.73
overall complication in hospital 0.51 (0.24, 1.01) 0.05
overall complication during follow up 0.56 (0.28, 1.06) 0.08
doi:10.1371/journal.pone.0079170.t005
Figure 2. BMI with incidence of meningioma and PE. The legend
for BMI is on the left side of the panel. The number of PE corresponding
to each age-group and the incidence of meningioma in percent is
quantified on the right side. All three factors increased with age until
the sixth decade and decreased with advanced age (.70 years).
doi:10.1371/journal.pone.0079170.g002
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Discussion
Venous thromboembolic complications are a major contributor
to morbidity following meningioma surgery and can be reduced by
the use of standardized protocols.[18].
In addition, the removal of meningiomas is frequently
associated with excessive intraoperative bleeding and an elevated
risk for postoperative intracranial hemorrhage. The rich vascula-
ture of meningioma is a contributing factor for local hemorrhag-
es.[4,5] Both postoperative hemorrhagic complications and VTE
mainly occur within the first 2 postoperative weeks after
meningioma resection[13,19]. Postoperative management in
meningioma surgery is therefore a balancing act between risking
venous thromboembolic events and risking hemorrhage. There is
a commonly agreed upon optimal strategy to prevent VTE using a
combined approach including physical and pharmacological
therapy.[18] IPC decreases the incidence of VTE by 50% and is
the preferred prophylaxis in neurosurgery.[17] Several studies
have shown that the combination of LMWH and compression
stockings is as safe as and more efficacious than compression
stockings alone.[6,17,18,20,21].
Alternative Prophylactic Regimens
In one study by Gerber et al., the VTE prophylaxis protocol
consisted of mechanical prophylaxis with preoperative TED
compression stockings and intermittent pneumatic compression.
Pharmacological prophylaxis with unfractionated heparin (5000
units subcutaneously) was started 24 hours postoperatively and
administered twice daily. Early postoperative ambulation was
started on the first postoperative day.[1].
Another DVT prophylaxis protocol was to administer elastic
stockings pre- and postoperatively, starting from the day of
hospitalization until the subjects were completely mobile. Me-
chanical graduate pneumatic sequential leg compression was
added perioperatively. Sodium tinzaparin (LMWH) was started 24
hours postoperatively, and in high-risk patients, tinzaparin was
administered regularly 5 to 7 days before surgery and stopped on
the day before surgery. After surgery, the application of tinzaparin
continued until the subjects were completely mobile. With high-
risk patients, tinzaparin was continued for at least 3 weeks
postoperatively.[15].
A third study administered enoxaparin (a LMWH) starting
between 24 h and 48 h as a subcutaneous injection after the
resection of an intracranial meningioma. The treatment lasted
between 1 and 7 days, usually with a dose of 40 mg daily. The use
of post-operative physical prophylaxis with TED stockings or
pneumatic sequential compression was also noted. [6] The rate of
both PE and DVT was 0% with enoxaparin. In the non-
enoxaparin group, the incidence of PE was 3.2%, and the
incidence of DVT was 4.8%. Hemorrhage occurred in 12.5% of
the enoxaparin-treated subjects and in 12.9% with the non-
enoxaparin treatment. These results suggest no increased risk of
postoperative hemorrhage after administration of LMWH. The
ACCP Guidelines recommend, for major neurosurgery patients,
routine thrombosis prophylaxis with the use of IPC or postoper-
ative LMWH or UFH. [22].
The routine administration of LMWH within the first 48 h after
the surgical resection of meningiomas seems to decrease the
incidence of postoperative thromboembolic events without
increased risk for bleeding complications.
Pulmonary Embolism
PE during the hospital stay decreased from 7.3% in cohort A to
1.7% in cohort B (p = 0.00055), and it decreased from 8% to 2.5%
(p= 0.0021) for the period from admission until a three-month
postoperative follow-up. This fact highlights the observation that
the majority of PEs occurred during hospitalization. For the PE
endpoint, a skull base location, a higher BMI and a longer hospital
stay are associated with a higher risk, as depicted in Figure 5.
Figure 3. (A) Average BMI of study subjects and average
national BMI. The registered BMI of subjects with a meningioma in
the years 1999–2010 (n = 574) was higher than the national BMI. Shown
are the proportions in weight categories based on BMI. (B) Incidence of
PE assigned to BMI-categories. The distribution of patients with PE,
depicted for BMI categories of the two cohorts separately.
doi:10.1371/journal.pone.0079170.g003
Figure 4. Comparison between meningioma locations. Cases
with a skull base location (A) had a higher risk for PE (OR: 2.77 with 95%
CI 1.15 to 7.07; p = 0.0096) compared to subjects with non-skull base
meningioma. (B). The difference of odds ratio (OR) estimates between
skull base and non-skull base meningioma is significant for DVT
(p = 0.02) and overall complication (p = 0.05).
doi:10.1371/journal.pone.0079170.g004
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Independent risk factors associated with the development of
DVT or PE included older age (P,0.0001), paresis (0.002), large
tumor size and a duration of surgery longer than 4 h.[23].
A longer hospital stay could be both a risk factor (immobiliza-
tion) and a consequence of PE. Our data do not allow that
discrimination. The decrease in PE is most likely due to the earlier
administration of heparin, perioperative IPC and extended
intraoperative leg positioning. The large decrease in PE in cohort
B was unexpected in relation to the stable rates of DVT in both
cohorts.
It is also interesting to note that the rate for DVT in cohort A is
lower than the rate of PE. This observation is counterintuitive, as
the common pathomechanism is a PE as a complication of a
DVT. However, the two diagnoses are made with different
diagnostic modalities, harboring a different sensitivity. PE is
diagnosed with a very sensitive method (contrast-enhanced spiral
CT of the thorax), and a diagnosis of DVT was not sought in all
PE cases, as PE and DVT end in a common therapeutic pathway
(anticoagulation).
Postoperative Hemorrhage
Postoperative hemorrhage following neurosurgical procedures
in patients receiving prophylactic heparin is reported to occur in
6% of meningioma procedures compared to 3.2% after other
major intracranial interventions.[14] In addition to tumor-specific
high vascularization, the intensity of the prophylactic anticoagu-
lation effect is most likely an important risk factor contributing to
intracerebral hemorrhage.[24,25] Any effective treatment that is
associated with a lower risk of bleeding would be use-
ful.[20,26]The incidence of postoperative hemorrhages decreased
from 6.7% in cohort A to 5% in cohort B. These rates of
hemorrhage are in accordance with the literature mentioned
above. This decrease was initially unexpected considering that the
earlier initiation of heparin administration (cohort B) should be
associated with a higher risk for hemorrhage. We assume that the
early postoperative CT scan in cohort B missed some postoper-
ative (clinically unapparent) bleedings that would have been
detected with a later CT scan, as administered in cohort A. In all
cases of significant postoperative hemorrhage, heparin adminis-
tration was delayed.
Skull Base Meningiomas
On one hand, skull base meningiomas were associated with the
highest rate of VTE in our study; on the other hand, these patients
showed the most pronounced benefit with an improved prophy-
lactic regimen (cohort B). Resections at the skull base frequently
require a long surgery duration (1 hour 24 minutes (37%) longer
than non-skull base lesions in our series).
Intraoperative hemostasis might be one factor contributing to
this higher incidence of VTE. In addition, the neurological
outcome is less favorable with skull base meningiomas.[27,28,29]A
skull base meningioma can enclose cranial nerves, the pituitary
stalk or vascular structures, and complete resections are both rare
and associated with a high morbidity.[29,30] Therefore, postop-
erative immobilization and blood stasis are increased in this
subgroup of meningiomas. Our data agree with research findings
that described a higher susceptibility to thromboembolic compli-
cations in subjects suffering from meningioma located at the skull
base.[8,31,32] Interestingly, the average operation duration in
skull base tumors increased from 5 hours 3 minutes in cohort A to
6 hours 1 minute in cohort B, indicating that the lower rate of
VTE in cohort B cannot be explained by a shorter surgery
duration and is more likely an effect of the new regimen.
Limitations of the Study
A rigorous comparison between two prophylactic regimens
should, of course, be performed in a prospective randomized
controlled trial. In our retrospective study, the subjects were
recruited over a period of eleven years and, in principle, several
aspects of the treatment might have changed in this period. The
improved outcome in cohort B could thus be regarded as progress-
related bias. However, progress-related bias was not present for
surgical technique, as no major progress occurred with respect to
meningioma treatment, and the approaches for rehabilitation have
also remained the same.
Regarding the detection of clinical symptoms, different treating
physicians might have had different thresholds for ordering a
diagnostic work-up regarding thromboembolic complications.
Additionally, smoking habits may have changed over time, and
the smoking status of the included patients was not assessed.
Table 6. Adjusted odds ratio results (change from cohort A to cohort B).
Endpoint OR (sb) CI OR (non-sb) CI P (diff) P (drop)
Hemorrhage 3 m f/u 0.25 (0.03,1.01) 1.2 (0.29,4.16) 0.12 0.15
death 3 m f/u 0.88 (0.04,7.28) 3.11 (0.11,93.37) 0.50 0.75
PE 3 m f/u 0.09 (0,0.53) 0.71 (0.01,3.43) 0.12 0.02
DVT 3 m f/u 0.28 (0.04,1.18) 4.2 (0.64,34.57) 0.03 0.07
Complication 3 m f/u 0.26 (0.09,0.67) 1.31 (0.5,3.35) 0.02 0.01
Shown are the odds ratio (OR) estimates with corresponding 95% confidence intervals (CIs) for patients with skull base location (sb) and other locations (non-sb) of the
tumor after 3 months of follow-up (3 m f/u). The difference between the two location groups was tested, and the p-value is reported (diff);additionally, the effect of
excluding the exposure variable was tested, giving the p-value in the right-most column (drop).
doi:10.1371/journal.pone.0079170.t006
Figure 5. PE associated factors. The comparison of cases with PE
and cases without PE showed that PE is significantly associated with skull
base meningioma (p= 0.01), prolonged hospital stay (p= 0.01 differ-
ence = 2.87 days) and higher BMI (p= 0.03 difference= 4.05 kg/m2).
doi:10.1371/journal.pone.0079170.g005
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Smoking is a known risk factor for developing thromboembolic
events. However, it seems unlikely that a systematic difference in
these aspects could be relevant to the difference between the two
cohorts or between skull base and non-skull base meningioma
patients.
To assess the neurological impact of the postoperative bleeding,
the subjects with postoperative hemorrhage would have to be
further stratified with respect to clot volume or the need for
surgical evacuation. While we assume that the rate of severe
hemorrhages has also decreased, the limited information available
from patient charts constrains us to report the reduction in CT-
findings between the two cohorts.
Conclusions
The introduction of the early postoperative application of UFH,
intraoperative leg extension and the application of IPC in addition
to LMWH and regular compression stockings significantly
reduced the rate of PE after meningioma surgery. The patients
with skull base meningiomas benefited the most from this
management.
The earlier administration of heparin (UFH) did not result in
increased complications from postoperative hemorrhage. We
recommend the management applied in cohort B, in particular
for patients with skull base meningiomas, to prevent perioperative
venous thromboembolic events.
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